Overview
Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)
Status:
Completed
Completed
Trial end date:
2003-11-01
2003-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to compare the gastrointestinal tolerability of an investigational drug to an approved drug in the treatment of osteoarthritis during one year treatment period.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Diclofenac
Etoricoxib
Criteria
Inclusion Criteria:- Osteoarthritis of the knee, hip, hand or spine which requires the use of medications
for pain relief
Exclusion Criteria:
- Known allergies to the study drugs